News
Regimen Beneficial for Waldenstrom Macroglobulinemia --Doctors ...
www.doctorslounge.com
Alessandra Tedeschi, M.D., from the Niguarda Ca' Granda Hospital in Milan, Italy, and colleagues investigated the efficacy of an FCR regimen in 43 patients with symptomatic WM, previously untreated or pretreated with one ...
MESH Program
www.iaria.org
Igor Podebrad, Klaus Hildebrandt, and Bernd Klauer. SECURWARE 4: ARCH IV Session chair: Reijo Savola. Detecting Man-in-the-Middle Attacks by Precise Timing ...
Leucemia linfatica cronica, ok Fda per ibrutinib in prima linea .:
www.pharmastar.it
La Food and Drug Administration ha dato il via libera all impiego in prima linea di ibrutinib per la cura dei pazienti con leucemia linfatica cronica. Per la...
Single-agent ibrutinib significantly prolongs survival in older...
www.healio.com
ORLANDO, Fla. — Ibrutinib monotherapy yielded superior PFS, OS, EFS and overall response rates compared with chlorambucil in older patients with chronic...
sorted by relevance / date